drugset / Trial / NCT04214717
Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor
RandomizedParallel-groupSingle-blindTreatment
Summary
Combinations of Dendritic cell-activated cytokine-induced killer cell (DC-CIK) With chemotherapy treatment may enhance the immune response and stop cancer cells from growing.
Timeline
- Start
- 2019-12-31
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DC-CIK | Cell therapy | — | — |